M R Graf

Summary

Affiliation: Virginia Commonwealth University
Country: USA

Publications

  1. ncbi Interleukin-6 transduction of a rat T9 glioma clone results in attenuated tumorigenicity and induces glioma immunity in Fischer F344 rats
    M R Graf
    Department of Neurosurgery, Virginia Commonwealth University and Medical College of Virginia, Richmond 23298 0709, USA
    J Neurooncol 45:209-18. 1999
  2. ncbi Development of systemic immunity to glioblastoma multiforme using tumor cells genetically engineered to express the membrane-associated isoform of macrophage colony-stimulating factor
    M R Graf
    Department of Molecular Biology, University of California, Irvine 92697, USA
    J Immunol 163:5544-51. 1999
  3. ncbi The anti-tumor effects of androstene steroids exhibit a strict structure-activity relationship dependent upon the orientation of the hydroxyl group on carbon-17
    Martin R Graf
    Department of Neurosurgery Harold F Young Neurosurgical Center and the Massey Cancer Center, Virginia Commonwealth University Medical Center, P O Box 980631, 1200 E Broad Street, Richmond, VA 23298 0631, USA
    Chem Biol Drug Des 74:625-9. 2009
  4. ncbi Autophagy and the functional roles of Atg5 and beclin-1 in the anti-tumor effects of 3beta androstene 17alpha diol neuro-steroid on malignant glioma cells
    Martin R Graf
    Department of Neurosurgery Harold F Young Neurosurgical Center and Massey Cancer Center, Virginia Commonwealth University Medical Center, PO Box 980631, Richmond, VA 23298 0631, USA
    J Steroid Biochem Mol Biol 115:137-45. 2009
  5. ncbi The neuro-steroid, 3beta androstene 17alpha diol exhibits potent cytotoxic effects on human malignant glioma and lymphoma cells through different programmed cell death pathways
    M R Graf
    Department of Neurosurgery and the Massey Cancer Center, Virginia Commonwealth University Medical Center, PO Box 980631, Richmond, VA 23298 0631, USA
    Br J Cancer 97:619-27. 2007
  6. ncbi Tumor infiltration by myeloid suppressor cells in response to T cell activation in rat gliomas
    Martin R Graf
    Department of Neurosurgery, Virginia Commonwealth University Medical Center, Richmond, Virginia, 23298 0631, USA
    J Neurooncol 73:29-36. 2005
  7. ncbi Contrasting effects of interleukin-2 secretion by rat glioma cells contingent upon anatomical location: accelerated tumorigenesis in the central nervous system and complete rejection in the periphery
    Martin R Graf
    Department of Anatomy and Neurobiology, Medical College of Virginia, Virginia Commonwealth University, P O Box 980709 MCV Station, Richmond, VA 23298 0709, USA
    J Neuroimmunol 140:49-60. 2003
  8. ncbi IL-6 secretion by a rat T9 glioma clone induces a neutrophil-dependent antitumor response with resultant cellular, antiglioma immunity
    M R Graf
    Division of Neurosurgery, Virginia Commonwealth University Medical College of Virginia, Richmond, VA 23198, USA
    J Immunol 166:121-9. 2001
  9. ncbi Irradiated tumor cell vaccine for treatment of an established glioma. I. Successful treatment with combined radiotherapy and cellular vaccination
    Martin R Graf
    Department of Anatomy and Division of Neurosurgery, Virginia Commonwealth University Medical College of Virginia, 1101 E Marshall Street, P O Box 980709, Richmond, VA 23198 0709, USA
    Cancer Immunol Immunother 51:179-89. 2002
  10. ncbi Cytotoxic T cells infiltrating a glioma express an aberrant phenotype that is associated with decreased function and apoptosis
    R M Prins
    Department of Anatomy, Virginia Commonwealth University Medical College of Virginia School of Medicine, Richmond 23298 0709, USA
    Cancer Immunol Immunother 50:285-92. 2001

Collaborators

Detail Information

Publications16

  1. ncbi Interleukin-6 transduction of a rat T9 glioma clone results in attenuated tumorigenicity and induces glioma immunity in Fischer F344 rats
    M R Graf
    Department of Neurosurgery, Virginia Commonwealth University and Medical College of Virginia, Richmond 23298 0709, USA
    J Neurooncol 45:209-18. 1999
    ..F parental cells (p = 0.003). This study demonstrates that IL-6 secretion attenuates SC and IC glioma growth and SC rejection of IL-6 secreting T9.F cells induces long-term glioma immunity which is effective in the brain...
  2. ncbi Development of systemic immunity to glioblastoma multiforme using tumor cells genetically engineered to express the membrane-associated isoform of macrophage colony-stimulating factor
    M R Graf
    Department of Molecular Biology, University of California, Irvine 92697, USA
    J Immunol 163:5544-51. 1999
    ..Subcutaneous immunization with viable T9/mM-CSF cells was effective in eradicating i.c. T9 tumors...
  3. ncbi The anti-tumor effects of androstene steroids exhibit a strict structure-activity relationship dependent upon the orientation of the hydroxyl group on carbon-17
    Martin R Graf
    Department of Neurosurgery Harold F Young Neurosurgical Center and the Massey Cancer Center, Virginia Commonwealth University Medical Center, P O Box 980631, 1200 E Broad Street, Richmond, VA 23298 0631, USA
    Chem Biol Drug Des 74:625-9. 2009
    ..These results indicate that the position of the hydroxyl group on C-17 dictates the anti-tumor activity of the androstenes and must be in the alpha-configuration, demonstrating a strict structure-activity relationship...
  4. ncbi Autophagy and the functional roles of Atg5 and beclin-1 in the anti-tumor effects of 3beta androstene 17alpha diol neuro-steroid on malignant glioma cells
    Martin R Graf
    Department of Neurosurgery Harold F Young Neurosurgical Center and Massey Cancer Center, Virginia Commonwealth University Medical Center, PO Box 980631, Richmond, VA 23298 0631, USA
    J Steroid Biochem Mol Biol 115:137-45. 2009
    ..These results demonstrate that 17alpha-AED possesses significant anti-glioma activity when used at pharmacologically relevant concentrations in vitro and the cytotoxic effects are resultant from the induction of autophagy...
  5. ncbi The neuro-steroid, 3beta androstene 17alpha diol exhibits potent cytotoxic effects on human malignant glioma and lymphoma cells through different programmed cell death pathways
    M R Graf
    Department of Neurosurgery and the Massey Cancer Center, Virginia Commonwealth University Medical Center, PO Box 980631, Richmond, VA 23298 0631, USA
    Br J Cancer 97:619-27. 2007
    ..These cytotoxic effects may utilize a non-apoptotic pathway in malignant glioma cells...
  6. ncbi Tumor infiltration by myeloid suppressor cells in response to T cell activation in rat gliomas
    Martin R Graf
    Department of Neurosurgery, Virginia Commonwealth University Medical Center, Richmond, Virginia, 23298 0631, USA
    J Neurooncol 73:29-36. 2005
    ..These results suggest that MSC infiltration and unregulated tumor growth in response to vaccination is T cell-dependent; is not unique to the T9 glioma; and can be recapitulated with an alternate immunization approach...
  7. ncbi Contrasting effects of interleukin-2 secretion by rat glioma cells contingent upon anatomical location: accelerated tumorigenesis in the central nervous system and complete rejection in the periphery
    Martin R Graf
    Department of Anatomy and Neurobiology, Medical College of Virginia, Virginia Commonwealth University, P O Box 980709 MCV Station, Richmond, VA 23298 0709, USA
    J Neuroimmunol 140:49-60. 2003
    ..F cells. Intracranial T9.F/IL2/#12 tumors were markedly infiltrated by CD4(+) and CD8(+) T cells, natural killer (NK)-T cells and myeloid progenitor cells, whereas subcutaneous T9.F/IL2/#12 tumors contained an elevated level of NK cells...
  8. ncbi IL-6 secretion by a rat T9 glioma clone induces a neutrophil-dependent antitumor response with resultant cellular, antiglioma immunity
    M R Graf
    Division of Neurosurgery, Virginia Commonwealth University Medical College of Virginia, Richmond, VA 23198, USA
    J Immunol 166:121-9. 2001
    ....
  9. ncbi Irradiated tumor cell vaccine for treatment of an established glioma. I. Successful treatment with combined radiotherapy and cellular vaccination
    Martin R Graf
    Department of Anatomy and Division of Neurosurgery, Virginia Commonwealth University Medical College of Virginia, 1101 E Marshall Street, P O Box 980709, Richmond, VA 23198 0709, USA
    Cancer Immunol Immunother 51:179-89. 2002
    ....
  10. ncbi Cytotoxic T cells infiltrating a glioma express an aberrant phenotype that is associated with decreased function and apoptosis
    R M Prins
    Department of Anatomy, Virginia Commonwealth University Medical College of Virginia School of Medicine, Richmond 23298 0709, USA
    Cancer Immunol Immunother 50:285-92. 2001
    ..These results suggest that the aberrant CTL phenotype found in the TIL of glioma-bearing rats may be novel signals for their impending death and degenerating anti-tumor immune function...
  11. ncbi Tumor-infiltrating, myeloid-derived suppressor cells inhibit T cell activity by nitric oxide production in an intracranial rat glioma + vaccination model
    Wentao Jia
    Department of Neurosurgery, Virginia Commonwealth, Richmond, VA 23298 0631, USA
    J Neuroimmunol 223:20-30. 2010
    ..These findings suggest that neuro-immunomodulation by MDSC in rat gliomas maybe mediated by a pathway requiring NO production...
  12. ncbi Irradiated tumor cell vaccine for treatment of an established glioma. II. Expansion of myeloid suppressor cells that promote tumor progression
    Robert M Prins
    Department of Anatomy, Virginia Commonwealth University Medical College of Virginia, 1101 E Marshall Street, P O Box 980709, MCV Station, Richmond, VA 23198 0709, USA
    Cancer Immunol Immunother 51:190-9. 2002
    ..Therefore, we believe that an MSC population is responsible for inhibiting the anti-tumor T cell response, resulting in the enhanced growth of the i.c. glioma, and may represent a significant obstacle to immune-based therapies...
  13. ncbi Effect of WT1 gene silencing on the tumorigenicity of human glioblastoma multiforme cells
    Aaron J Clark
    Department of Anatomy and Neurobiology, Virginia Commonwealth University, Medical College of Virginia Campus, Richmond, Virginia 23298 0631, USA
    J Neurosurg 112:18-25. 2010
    ..Studies of nonglioma cell lines have demonstrated that WT1 promotes cell proliferation and survival; however, this ability has not been rigorously analyzed in human GBM...
  14. ncbi Down-regulation of Wilms' tumor 1 expression in glioblastoma cells increases radiosensitivity independently of p53
    Aaron J Clark
    Department of Neurosurgery, Virginia Commonwealth University, Medical College of Virginia Campus, Richmond, VA 23298 0631, USA
    J Neurooncol 83:163-72. 2007
    ..Anti-WT1 strategies may, therefore, prove useful in improving the response of glioblastoma to radiotherapy, thus potentially improving patient survival...
  15. ncbi Thymic function and output of recent thymic emigrant T cells during intracranial glioma progression
    Robert M Prins
    Department of Anatomy and Surgery, Virginia Commonwealth University/Medical College of Virginia, Richmond, VA, USA
    J Neurooncol 64:45-54. 2003
    ..Our findings may shed light on the significance of thymic function for anti-glioma immunity and the response to immunotherapeutic treatment paradigms...
  16. ncbi FTY720 reduces inflammation and promotes functional recovery after spinal cord injury
    Kangmin D Lee
    Department of Neurosurgery, Virginia Commonwealth University, Richmond, Virginia, USA
    J Neurotrauma 26:2335-44. 2009
    ..Collectively these results demonstrate the neuroprotective potential of FTY720 treatment after experimental SCI...